- Home
- HUMA vs IIF Comparison
HUMA vs IIF Comparison
Compare HUMA & IIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HUMA | IIF |
|---|---|---|
| Founded | 2004 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.6M | 252.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | HUMA | IIF |
|---|---|---|
| Price | $1.06 | $25.16 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $10.13 | N/A |
| AVG Volume (30 Days) | ★ 4.9M | 45.4K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 13.94% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,571,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $698.97 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.91 | $18.95 |
| 52 Week High | $5.48 | $24.41 |
Technical Indicators
Market Signals| Indicator | HUMA | IIF |
|---|---|---|
| Relative Strength Index (RSI) | 41.80 | 31.46 |
| Support Level | $0.91 | $24.77 |
| Resistance Level | $1.17 | $25.58 |
| Average True Range (ATR) | 0.08 | 0.32 |
| MACD | -0.00 | -0.09 |
| Stochastic Oscillator | 38.46 | 13.37 |
Price Performance
Historical ComparisonAbout HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
About IIF Morgan Stanley India Investment Fund Inc.
Morgan Stanley India Investment Fund, Inc. is the United States based non-diversified, closed-end management investment company. Its investment objective is to achieve long-term capital appreciation through investment in equity securities of Indian Issuers. The company's portfolio of investments consists of the investment in different sectors such as auto components, banks, capital markets, construction and engineering, pharmaceuticals and others.